Synapse - Neeta Pandit-Taskar

Results (44)

Pharmacokinetics, biodistribution, and radiation dosimetry for (89)Zr-trastuzumab in patients with esophagogastric cancer

Journal Article

O'Donoghue, J. A.; Lewis, J. S.; Pandit-Taskar, N.; Fleming, S. E.; Schöder, H.; Larson, S. M.; Beylergil, V.; Ruan, S.; Lyashchenko, S. K.; Zanzonico, P. B.; more...
Journal of Nuclear Medicine (2018)

Fulltext@MSK | Save

First-in-human imaging with (89)Zr-Df-IAB2M Anti-PSMA minibody in patients with metastatic prostate cancer: Pharmacokinetics, biodistribution, dosimetry, and lesion uptake

Journal Article

Pandit-Taskar, N.; O'Donoghue, J. A.; Ruan, S.; Lyashchenko, S. K.; Carrasquillo, J. A.; Heller, G.; Martinez, D. F.; Cheal, S. M.; Lewis, J. S.; Fleisher, M.; more...
Journal of Nuclear Medicine (2016)

Fulltext@MSK | Save

First in-human study: 18F-FDG PET/CT positron lymphography maps sentinel lymph nodes in early-stage cervical and endometrial cancer

Meeting Abstract

Mueller, J.; Soslow, R.; Jewell, E.; Dauer, L.; John, H.; Pandit-Taskar, N.; Abu-Rustum, N.; Grimm, J.
International Journal of Gynecological Cancer (2016)

Fulltext@MSK | Save

A phase I/IIa trial of prostate specific membrane antigen (PSMA) positron emission tomography (PET) imaging with (89)Zr-Df-IAB2M in metastatic prostate cancer (PCa)

Meeting Abstract

Morris, M. J.; Martinez, D. F.; Durack, J. C.; Slovin, S. F.; Danila, D. C.; O'Donoghue, J. A.; Parada, N. A.; Lyashchenko, S. K.; Carrasquillo, J. A.; Ruan, S.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

PET-based compartmental modeling of (124)I-A33 antibody: Quantitative characterization of patient-specific tumor targeting in colorectal cancer

Journal Article

Zanzonico, P.; Carrasquillo, J. A.; Pandit-Taskar, N.; O'Donoghue, J. A.; Humm, J. L.; Smith-Jones, P.; Ruan, S.; Divgi, C.; Scott, A. M.; Kemeny, N. E.; more...
European Journal of Nuclear Medicine and Molecular Imaging (2015)

Fulltext@MSK | Save

Pathologic correlation of (89)Zr-Df-IAB2M antiprostate-specific membrane antigen (PSMA) minibody in patients with metastatic prostate cancer

Meeting Abstract

Morris, M. J.; Solomon, S. B.; Durack, J. C.; O'Donoghue, J. A.; Lyashchenko, S. K.; Ruan, S. T.; Carrasquillo, J. A.; Lewis, J. S.; Martinez, D. F.; Parada, N. A.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Minibody imaging of prostate-specific membrane antigen (PSMA): From concept in clinic

Meeting Abstract

Olafsen, T.; Bartlett, D.; Ho, D.; Zhang, G.; Torgov, M.; Keppler, J.; Behrenbruch, C.; Wu, A.; Pandit-Taskar, N.; Morris, M. J.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer

Journal Article

Pandit-Taskar, N.; O'Donoghue, J. A.; Beylergil, V.; Lyashchenko, S.; Ruan, S.; Solomon, S. B.; Durack, J. C.; Carrasquillo, J. A.; Lefkowitz, R. A.; Gonen, M.; more...
European Journal of Nuclear Medicine and Molecular Imaging (2014)

Fulltext@MSK | Save

Tumor-directed PET imaging of bone metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled anti-prostate specific membrane antigen (PSMA) antibody J591

Meeting Abstract

Morris, M. J.; Pandit-Taskar, N.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; Beylergil, V.; O'Donoghue, J. A.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Phase I trial of zirconium 89 (Zr89) radiolabeled J591 in metastatic castration-resistant prostate cancer (mCRPC)

Meeting Abstract

Morris, M. J.; Pandit-Taskar, N.; Carrasquillo, J. A.; O'Donoghue, J. A.; Humm, J.; Lyashchenko, S. K.; Haupt, E. C.; Bander, N. H.; Tagawa, S. T.; Holland, J. P.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save